MEDX ... anybody following? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following?

MEDX 31.14

-0.1%

10:04 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: nigel bates	8/28/2009 4:53:23 AM
	of 2240

Finis. NEW YORK (AP) -- Bristol-Myers Squibb Co. said Thursday it completed its initial tender offer for shares of Medarex Inc., a rival it agreed to buy for $2.1 billion. Bristol-Myers said 87.7 percent of Medarex stock, or a total of 119 million shares, were tendered. The company is preparing for an additional tender offer in which it will try to buy the remaining shares. That period is expected to close by Monday. According to Bristol-Myers, the sale will finish faster if more than 90 percent of Medarex shares are tendered. Even if that does not happen, the deal is expected to close by the end of 2009. Bristol-Myers offered $16 per share for the Princeton, N.J., biotechnology company on July 22.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next